Harry Glorikian

Harry Glorikian Email and Phone Number

General Partner Scientia Ventures @ Scientia Ventures
Harry Glorikian's Location
Greater Boston, United States, United States
Harry Glorikian's Contact Details
About Harry Glorikian

GLOBAL EXECUTIVEI am a global executive with 20+ years of influential leadership in life sciences, healthcare, and healthcare IT. Known for operational experience, definitive business strategy, execution, IT excellence, and large-scale reinvention, I am a driving force behind major business transformations that accelerated growth, efficiency gains, cost reductions, and competitive advantage for market leaders as well as up-and-coming innovators with next-generation ideas. PAST POSITIONS-Senior Advisor - Precision for Medicine-Managing Director for Precision for Medicine, providing the vision, leadership, and a vast network of strategic global relationships to help life science innovators develop and commercialize next-generation medical products-Co-Founder and Managing Partner of Scientia Advisors, global consultancy providing strategic expertise to healthcare, life sciences, pharma, biotech, medical device, diagnostic and healthcare IT organizationsTHOUGHT LEADER & SUBJECT MATTER EXPERT-Dow Jones, The Boston Globe, BioWorld Today, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, CBS Evening News, XconomyBOARD SERVICE-Nucelis: Compensation & HR Committee; Strategy Committee; Independent Board Member-GeneNews Ltd. (GEN: Toronto): Compensation & HR Committee Chair; Strategy Committee; Special Committee Member; Independent Board Member-Draper Laboratories: Life Sciences Advisory BoardRECENT SPEAKING ENGAGEMENTS (LIST AVAILABLE)-Oracle - Precision Medicine & Omics Data in Care Delivery: Stories from the Pioneers-Sachs Cancer Bio Partnering Forum Promoting Public & Private Sector Collaboration & Investment in Drug Development-Cleveland Clinic’s Personalized Healthcare Summit Molecular Test Development: Considerations & Lessons Learned-Molecular Medicine Tri-Con 2014 Molecular Diagnostics: Next Wave of Personalized Medicine

Harry Glorikian's Current Company Details
Scientia Ventures

Scientia Ventures

View
General Partner Scientia Ventures
Harry Glorikian Work Experience Details
  • Scientia Ventures
    General Partner
    Scientia Ventures Dec 2016 - Present
    New York, Ny, Us
    The Scientia Ventures team is a group of co-founders, entrepreneurial operators, and investors whose members have collaborated on various projects together in the healthcare industry.We have repeatedly created, invested in, and exited multiple companies in therapeutics, precision medicine, diagnostics, and various high impact technology verticals.Through our deep domain expertise and insight, we are able to translate transformational science into successful business ventures. Our experience allows us to create companies around acquired IP or invest in traditional early stage companies.
  • Consilience Ai
    Co-Founder And Ceo
    Consilience Ai Apr 2021 - Present
    AI Solutions Delivering Tomorrow's Knowledge TodayWe have built scalable and explainable AI solutions to deliver mission critical insights by uncovering hidden relationships in data.
  • The Harry Glorikian Show
    Host Of The Harry Glorikian Show
    The Harry Glorikian Show Sep 2018 - Present
    The power of data is remaking everything in healthcare—not just the way doctors diagnose patients, but the way pharma companies develop drugs and the way hospitals and insurers control costs and create value. Here at The Harry Glorikian Show, host Harry Glorikian talks with the executives, entrepreneurs, physicians, and scientists who are pushing that high-tech revolution forward. Harry's 2017 book "MoneyBall Medicine" offered an inside look at the ways genomics, machine learning, and other trends are improving healthcare delivery and efficiency. In his subsequent book published in 2021 - The Future You, How Artificial Intelligence Can Help You Get Healthier, Stress Less and Live Longer explores how AI is disrupting healthcare and what everyone needs to know to navigate the new medical paradigm and improve your own personal health.
  • Harry Glorikian
    Ceo/Senior Executive/Board Director
    Harry Glorikian May 2014 - Present
    Senior Executive | Board Director | Investor – Life Sciences | Biotech | Big Data | Healthcare | Digital Health | Author
  • Northeastern University
    Member Of Northeastern University Bioengineering Industrial Advisory Board
    Northeastern University Jul 2022 - Present
    Boston, Ma, Us
    The Bioengineering Industrial Advisory Board unites a diverse group of bright and enterprising leaders from across the sector to create a strong resource pool for students, faculty, and administrators, as the department continues to grow and thrive.
  • Beth Israel Deaconess Medical Center
    Member Of Industry Advisory Committee
    Beth Israel Deaconess Medical Center Sep 2020 - Present
    Boston, Ma, Us
    Member of Industry Advisory CommitteeMusculoskeletal Translational Innovation InitiativeCarl J Shapiro Department of Orthopaedic SurgeryBeth Israel Deaconess Medical Center
  • Stagezero Life Sciences
    Member Board Of Directors
    Stagezero Life Sciences Jul 2008 - Present
    Richmond Hill, Ontario, Ca
    Independent Board DirectorDirector, Chairman of Compensation & Human Resources Committee Member of Strategy Committee
  • Biocartis
    Board Of Directors
    Biocartis May 2018 - May 2020
    Mechelen, Be
  • Drawbridge Health
    Advisor And Co-Founder
    Drawbridge Health Aug 2015 - May 2020
    New York, Ny, Us
    Drawbridge Health – Making Sampling SimplerDrawbridge Health is a medical technology company fusing the science of chemistry with the fundamentals of logistics to access and immediately stabilize the blood sampling process, anywhere. Their mission is to power the shift in healthcare from being reactive to proactive, enabling predictive medicine to be realized by bridging diagnostic testing from sample to delivery to decision. This transformation begins with how they approach the collection and interpretation of medical diagnostic tests—the data that they use to make nearly all of medical decisions. The current sample collection and testing paradigm is not only inconvenient and costly for consumers and medical providers alike, but is incomplete and not tailored to the individual. Drawbridge Health is building a new sample acquisition and stabilization platform to enable the broad access, accurate, and actionable information necessary to pave the way for truly individualized and predictive healthcare.
  • Evidation Health
    Advisory Board
    Evidation Health Mar 2015 - 2018
    San Mateo, California, Us
    Evidation Health Advisory Board Member - Assisted in the planning of the company and continue to assist in the long term strategy and plan for growth. Evidation Health seeks to improve health outcomes through clinically and economically beneficial digital health solutions and new approaches to predictive analytics.
  • Cibus
    Member Board Of Advisors
    Cibus 2012 - 2017
    San Diego, California, Us
    Nucelis was merged into CibusNucelis delivers high-value, performance-focused and sustainably-sourced ingredient solutions to the personal care, nutrition and flavor and fragrance markets. This is accomplished by leveraging their proprietary, non-transgenic gene editing technologies and integrated production development platform.
  • Cepheid
    Strategic Advisory Board Member
    Cepheid May 2014 - Nov 2016
    Sunnyvale, Ca, Us
    Advisory Board Member - Helping develop the long-term strategy and plan for growth
  • Ge Ventures, New Business Creation
    Entrepreneur In Residence
    Ge Ventures, New Business Creation Oct 2014 - Apr 2016
    Chicago, Us
    Entrepreneur in Residence - co-founding newcos from the ground up - ideation, identifying the market opportunity, developing the offering concept, coordinating the market analysis, development of the business and operating plans, asset/IP understanding, financing, hiring and partnering strategies
  • Draper
    Member, Biomedical Advisory Board
    Draper Sep 2006 - Jul 2015
    Cambridge, Ma, Us
    Advisory Board Member - helping develop Draper’s long-term strategy and plan for growing the biomedical business area.
  • Precision For Medicine
    Senior Advisor
    Precision For Medicine Mar 2014 - Apr 2014
    Bethesda, Md, Us
  • Precision For Medicine
    Managing Director
    Precision For Medicine Nov 2012 - Mar 2014
    Bethesda, Md, Us
    * Brought on board to provide vision, leadership, and a vast network of strategic global relationships to create a world-class life sciences service provider organization for innovators in next-generation medical products.
  • Scientia Advisors
    Managing Partner
    Scientia Advisors Jun 2004 - Mar 2014
    Cambridge, Ma, Us
    Scientia Advisors is an international strategy & management consulting firm with a concentration in life sciences & healthcare.Co-Founder & Managing Partner* Built the organization from the ground up. All operational aspects - HR, Marketing, Etc. * Provided entrepreneurial vision and expertise in creating and growing a financially vibrant and operationally sound organization of consulting professionals. * Built solid international reputation as a go-to firm for strategic advice in healthcare and life sciences.* Expanded service offerings to operations implementation, pricing, and nation-based expansion on a global scale.* Established ScientiaNET, the global network of nearly 135,000 science and business opinion leaders and SMEs. * Continued to grow client portfolio, revenue, headcount, and profitability in spite of economic recession.
  • Applied Biosystems
    Senior Manager, Business Development
    Applied Biosystems Mar 1997 - Mar 2004
    Waltham, Ma, Us
    * Executed a number of different roles – including Product Manager for Immunoassay Technologies, Product Manager for DNA Synthesis, and Senior Manager, Global Business Development – as the company experienced phenomenal growth, serial reorganization, and scientific innovation.* Played key roles in genomics and proteomics; within 4 years, division revenues more than doubled to $1.6 billion.* Frequently called on to plan and manage special projects based on reputation for aggressively pushing forward the decision-making process of C-suite management for high-impact results.* Conceived, developed the strategy, and gained executive approval for $32.8M acquisition of Boston Probes, opening the door for new opportunities in peptide nucleic acid probe technology.
  • Signet Laboratories
    National Sales Manager
    Signet Laboratories 1994 - 1997
    * Recruited to kick-start a stagnant sales presence and marketing process.* Built sales force from the ground up; established IT network and CRM software; rebuilt R&D function; reformulated key product line.* Developed and taught immunohistochemistry (IHC) process courses to researchers, physicians, and technicians.
  • X-Cell Laboratories
    Co-Founder
    X-Cell Laboratories 1993 - 1994
    * Built X-Cell from ground up to significant revenue run rate and created the formulation for novel IHS reagent set, favorable positioning the company for quick acquisition.
  • Biogenex Laboratories
    Sales & Marketing Manager
    Biogenex Laboratories 1990 - 1993
    * Excelled in first sales role as top performer every year.* Doubled sales in 3 territories in less than 3 years.* Proactively developed and taught 60-80 CEU-approved courses on immunohistochemistry (a new area in pathology labs) to technologists and pathologists.* Gained reputation as sought after IHC SME speaker.

Harry Glorikian Skills

Biotechnology Start Ups Commercialization Medical Devices Life Sciences Entrepreneurship Technology Transfer Management Consulting Strategic Planning Product Management Business Strategy Cross Functional Team Leadership Genomics R&d Product Development Molecular Biology Oncology Healthcare Market Analysis Biopharmaceuticals Marketing Strategy Product Launch Competitive Analysis New Business Development Drug Discovery Venture Capital Corporate Development Infectious Diseases Technology Evaluation Due Diligence Personalized Medicine Business Planning Science Licensing Mergers Global Marketing Competitive Intelligence Sales Management Marketing Management Intellectual Property Negotiation Patents Product Launches Clinical Diagnostics Diagnostics Clinical Strategy Development Pharmaceuticals In Vitro Technology Commercialization

Harry Glorikian Education Details

  • Boston University
    Boston University
    Mba
  • San Francisco State University
    San Francisco State University
    Biology

Frequently Asked Questions about Harry Glorikian

What company does Harry Glorikian work for?

Harry Glorikian works for Scientia Ventures

What is Harry Glorikian's role at the current company?

Harry Glorikian's current role is General Partner Scientia Ventures.

What is Harry Glorikian's email address?

Harry Glorikian's email address is hg****@****adv.com

What is Harry Glorikian's direct phone number?

Harry Glorikian's direct phone number is +161748*****

What schools did Harry Glorikian attend?

Harry Glorikian attended Boston University, San Francisco State University.

What are some of Harry Glorikian's interests?

Harry Glorikian has interest in Electronics.

What skills is Harry Glorikian known for?

Harry Glorikian has skills like Biotechnology, Start Ups, Commercialization, Medical Devices, Life Sciences, Entrepreneurship, Technology Transfer, Management Consulting, Strategic Planning, Product Management, Business Strategy, Cross Functional Team Leadership.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.